STAT3 and hepatocellular carcinoma: Recently, abnormal SHP-1/p-STAT3 signaling pathway was identified in various human malignant tumors, including multiple myeloma [20], hepatocellular carcinoma [21], breast cancer [22] and triple-negative breast cancer [23].